Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Investing.com -- Generate Biomedicines has filed for an initial public offering on Monday, aiming to raise as much as $425 million in the United States. The biotechnology company plans to offer 25 ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Although naturally occurring proteins form stable defined tertiary structures, it is well known that many proteins with non-natural sequences have unstructured conformations 1,2. This suggests that ...

Entrepreneurship can promote economic growth, even if its benefits are sometimes overhyped Diane Costagliola is a researcher, librarian, instructor, and writer who has published articles on personal ...

Gemini Can Now Generate 30-Second Songs From Text, Images with Lyria 3 You don't have to provide the lyrics. Just mention the mood and tempo or upload an image for reference, and let Lyria 3 do the ...